Birgitta Fromgren

Title: Birgitta Fromgren: Innovator in Vaccine Development

Introduction

Birgitta Fromgren is a prominent inventor based in Uppsala, Sweden. She has made significant contributions to the field of vaccine development, particularly through her innovative research and patented inventions. With a total of 2 patents, Fromgren's work focuses on the use of fibronectin binding proteins and peptides in vaccine compositions.

Latest Patents

Fromgren's latest patents include a vaccine composition that comprises a fibronectin binding protein or a fibronectin binding peptide. This invention relates to a composition that includes at least one fibronectin binding protein, a truncated fibronectin binding protein, and/or a fibronectin binding peptide, all containing at least one fibronectin binding domain. The composition also incorporates an Iscom matrix complex, liposome, lipid, and saponin, which may be in complex, solution, or suspension form. The invention aims to prepare a vaccine against microorganisms that possess at least one fibronectin binding domain. Additionally, it includes a kit of parts with compartments for the fibronectin binding protein and instructions for use, as well as a method for vaccinating individuals.

Career Highlights

Birgitta Fromgren has established herself as a key figure in the biotechnology sector, particularly through her work at Isconova AB. Her research has been instrumental in advancing vaccine technology, and her patents reflect her commitment to improving public health through innovative solutions.

Collaborations

Fromgren has collaborated with notable colleagues, including Bror Morein and Jill Ekstrom. These partnerships have further enhanced her research and contributed to the development of effective vaccine strategies.

Conclusion

Birgitta Fromgren's contributions to vaccine development through her innovative patents highlight her role as a leading inventor in the field. Her work continues to impact the biotechnology industry and public health positively.